Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-03-01 @ 3:54 PM
Study NCT ID:
NCT05903703
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-15
First Post:
2023-05-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Canagliflozin With Gemcitabine in Pancreatic Carcinoma
Sponsor:
Zhang Xiaofeng,MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20230519
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None